Suppr超能文献

肝移植术后再灌注肝活检及其在预测肝移植术后死亡率和移植物功能障碍方面的价值。

POST-REPERFUSION LIVER BIOPSY AND ITS VALUE IN PREDICTING MORTALITY AND GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION.

作者信息

Zanchet Marcos Vinícius, Silva Larissa Luvison Gomes da, Matias Jorge Eduardo Fouto, Coelho Júlio Cezar Uili

机构信息

Postgraduate Program im Sugical clinics, Healtu Sciences Sector, Federal University of Paraná, Curitiba, PR, Brazil.

出版信息

Arq Bras Cir Dig. 2016 Jul-Sep;29(3):189-193. doi: 10.1590/0102-6720201600030014.

Abstract

BACKGROUND

The outcome of the patients after liver transplant is complex and to characterize the risk for complications is not always easy. In this context, the hepatic post-reperfusion biopsy is capable of portraying alterations of prognostic importance.

AIM

To compare the results of liver transplantation, correlating the different histologic features of the hepatic post-reperfusion biopsy with graft dysfunction, primary non-function and patient survival in the first year after transplantation.

METHOD

From the 377 transplants performed from 1996 to 2008, 164 patients were selected. Medical records were reviewed and the following clinical outcomes were registered: mortality in 1, 3, 6 and 12 months, graft dysfunction in varied degrees and primary graft non-function. The post-reperfusion biopsies had been examined by a blinded pathologist for the outcomes. The following histological variables had been evaluated: ischemic alterations, congestion, steatosis, neutrophilic exudate, monomorphonuclear infiltrate and necrosis.

RESULTS

The variables associated with increased mortality were: steatosis (p=0.02209), monomorphonuclear infiltrate (p=0.03935) and necrosis (p<0.00001). The neutrophilic exudate reduced mortality in this study (p=0.00659). The primary non-function showed significant association (p<0.05) with the necrosis, steatosis and the monomorphonuclear infiltrate.

CONCLUSION

Post-reperfusion biopsy is useful tool to foresee complications after liver transplant.

摘要

背景

肝移植患者的预后情况复杂,确定并发症风险并非总是易事。在此背景下,肝再灌注活检能够描绘出具有预后重要性的改变。

目的

比较肝移植结果,将肝再灌注活检的不同组织学特征与移植后第一年的移植物功能障碍、原发性无功能及患者生存率相关联。

方法

从1996年至2008年进行的377例移植手术中选取164例患者。回顾病历并记录以下临床结果:1、3、6和12个月时的死亡率、不同程度的移植物功能障碍及原发性移植物无功能。由一位不知情的病理学家检查再灌注活检结果以评估以下组织学变量:缺血性改变、充血、脂肪变性、中性粒细胞渗出、单核细胞浸润和坏死。

结果

与死亡率增加相关的变量为:脂肪变性(p = 0.02209)、单核细胞浸润(p = 0.03935)和坏死(p < 0.00001)。在本研究中,中性粒细胞渗出降低了死亡率(p = 0.00659)。原发性无功能与坏死、脂肪变性和单核细胞浸润显示出显著相关性(p < 0.05)。

结论

再灌注活检是预测肝移植后并发症的有用工具。

相似文献

1
POST-REPERFUSION LIVER BIOPSY AND ITS VALUE IN PREDICTING MORTALITY AND GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION.
Arq Bras Cir Dig. 2016 Jul-Sep;29(3):189-193. doi: 10.1590/0102-6720201600030014.
3
Ischemic Postconditioning of the Liver Graft in Adult Liver Transplantation.
Transplantation. 2015 Aug;99(8):1633-43. doi: 10.1097/TP.0000000000000685.
4
Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy.
Liver Transpl. 2015 Jun;21(6):838-46. doi: 10.1002/lt.24123. Epub 2015 May 9.
7
Early markers of reperfusion injury after liver transplantation: association with primary dysfunction.
Hepatobiliary Pancreat Dis Int. 2015 Jun;14(3):246-52. doi: 10.1016/s1499-3872(15)60384-8.
10
Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis.
Virchows Arch. 2017 Feb;470(2):197-204. doi: 10.1007/s00428-016-2047-1. Epub 2016 Dec 3.

引用本文的文献

2
Comprehensive Approach to Assessment of Liver Viability During Normothermic Machine Perfusion.
J Clin Transl Hepatol. 2023 Apr 28;11(2):466-479. doi: 10.14218/JCTH.2022.00130. Epub 2022 Sep 13.
3
Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation.
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1133-1141. doi: 10.1016/j.jceh.2021.12.015. Epub 2022 Jan 4.
4
THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION.
Arq Bras Cir Dig. 2018;31(2):e1370. doi: 10.1590/0102-672020180001e1370. Epub 2018 Jul 2.
5
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Arq Bras Cir Dig. 2018 Jun 21;31(1):e1360. doi: 10.1590/0102-672020180001e1360.
6
BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION.
Arq Bras Cir Dig. 2017 Apr-Jun;30(2):127-131. doi: 10.1590/0102-6720201700020011.
7
ATORVASTATIN CAN PREVENT HEPATIC REMOTE REPERFUSION INJURY.
Arq Bras Cir Dig. 2017 Jul-Sep;30(3):197-200. doi: 10.1590/0102-6720201700030008.

本文引用的文献

3
Current status and perspective of liver preservation solutions.
Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):490-4.
5
Liver biopsy in evaluation of complications following liver transplantation.
World J Gastroenterol. 2004 Jun 1;10(11):1678-81. doi: 10.3748/wjg.v10.i11.1678.
8
Primary graft dysfunction after liver transplantation.
Transplant Proc. 2000 Nov;32(7):2219-20. doi: 10.1016/s0041-1345(00)01642-0.
9
Hepatocellular oxidative stress and initial graft injury in human liver transplantation.
J Hepatol. 1999 Nov;31(5):921-7. doi: 10.1016/s0168-8278(99)80295-5.
10
Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation.
Transplant Proc. 1999 Feb-Mar;31(1-2):550-1. doi: 10.1016/s0041-1345(98)01550-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验